In addition to diseases such as hypertension, treatment with inhibitors of the renin-angiotensin-aldosterone system (RAAS) causes an upregulation of ACE2 expression; this has led to the hypothesis that ACE inhibitor therapy may predispose patients to more severe COVID-19 courses [2,3,4,5,6]. This evidence concerns the gene ACE2 and Hypertension.